ArticleBlood advances2023
Schuelke MR, Bassiri H, Behrens EM, et al. Emapalumab for the treatment of refractory cytokine release syndrome in pediatric patients. Blood Adv. 2023;7(18):5603-5607.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.